trial

Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia

NCTId NCT07659938
as of 2026-07-01
at a glance
· Not Yet Recruiting
Enrollment 30 (estimated)
Sponsored by BioSignal Solutions LLC
Primary completion 2028-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Not Yet Recruiting
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2027-04
Primary completion
2028-06
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Sponsors

Sites

1 total
La Jolla, United States

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2028-06
Status
NOT_YET_RECRUITING